HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hanyang Yu Selected Research

erythrose (threose)

12/2020Selection of threose nucleic acid aptamers to block PD-1/PD-L1 interaction for cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hanyang Yu Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 12/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1Fatigue
01/2022
1Keratoconus
01/2022
1Breast Neoplasms (Breast Cancer)
08/2021
1Liver Neoplasms (Liver Cancer)
11/2020
1Cerebral Hemorrhage
04/2018

Drug/Important Bio-Agent (IBA)

2Nucleic AcidsIBA
01/2022 - 12/2020
1ClathrinIBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1Antigen Receptors (Antigen Receptor)IBA
01/2022
1Epirubicin (Ellence)FDA LinkGeneric
01/2022
1DNA (Deoxyribonucleic Acid)IBA
08/2021
1Platelet-Derived Growth FactorIBA
08/2021
1erythrose (threose)IBA
12/2020
1PlatinumIBA
11/2020
1Ribosomal DNA (rDNA)IBA
11/2020
1Pharmaceutical PreparationsIBA
11/2020
1Transcription Factors (Transcription Factor)IBA
11/2020
1ProcalcitoninIBA
04/2018

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2022
1Lasers (Laser)
01/2022
1Therapeutics
01/2022
1Immunotherapy
12/2020